DUBLIN--(BUSINESS WIRE)--The "Infusion Pumps and Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
Infusion pumps offer significant advantages over manual administration of infusion therapy, such as administration of accurate and continuous infusion therapy, the ability to deliver fluids at precisely programmed rates or automated intervals, etc. Moreover, the rapid development of pharmaceuticals and prescribed combinations has made infusion therapy more challenging than ever before. Thus, the use of infusion pumps to reduce infusion errors is growing worldwide. Since the last decade, many highquality infusion pumps with intelligent technologies and services have entered the market to make infusion therapy simpler, smarter and safer.
Automation and smart technology can drive improved patient safety, ensure timely, effective clinical intervention and help address the shortage of healthcare workers, a reality that is accelerating interest in solutions like these. With increasing pressure to control healthcare spending per capita, there is an increasing focus on using technology to increase productivity and reduce ancillary costs worldwide. Healthcare payers and providers continue to seek ways to optimize therapies and devices, resulting in improved outcomes, reduced costs, and ultimately, earlier discharge from hospitals, including recovery and treatment in non-acute settings. Thus, there is increasing demand for safety-driven, patient-focused and clinician-friendly infusion pumps.
Recently, the infusion pump market has been troubled with security concerns and product recalls. The ability to effectively compete in this market segment is determined by the company's ability to build its brand strength using the development of technological advancements aimed at increasing the quality, reliability, safety, and security of its infusion pumps while at the same time focusing on manufacturing efficiency and cost-effectiveness, which are operationally challenging with evolving product lines.
The global infusion pump market is expected to grow significantly, driven by macro trends relating to growing and aging populations, increasing chronic and lifestyle-related diseases, and accelerating demand for technologically advanced products. The infusion pump market has also been benefiting from rising healthcare demands in emerging markets.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Market Dynamics
Market Drivers
- Growing and Aging Population
- The Growing Number of Chronically Ill and Multimorbid Patients
- Rising Demand for Ambulatory Infusion Pumps, Especially in Home Care Settings
- Technological Advancements
- Increasing Number of Global Surgeries
- Rising Demand in Emerging Markets
- Rising Expectations for Increasing Quality of Care
Market Restraints
- Stringent Regulatory Landscape
- Security Concerns and Product Recalls
- Pricing Pressure
- Increasing Adoption of Refurbished and Rental Infusion Pumps
Chapter 5 Market Breakdown by Product Type
Chapter 6 Market Breakdown by Region
Chapter 7 Market Breakdown by Therapeutic Application
Chapter 8 Market Breakdown by End-user
Chapter 9 Regulatory Structure
Chapter 10 Impact of Covid-19
Chapter 11 Competitive Landscape
Chapter 12 Company Profiles
Chapter 13 Appendix: List of Acronyms
Companies Mentioned
- Abbott Laboratories
- Amsino International Inc.
- Avanos Medical Inc.
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson and Co.
- Cardinal Health
- Eitan Medical Ltd.
- Flowonix Medical Inc.
- Fresenius Kabi AG
- Icu Medical Inc.
- Insulet Corp.
- Intera Oncology
- Iradimed Corp.
- Koru Medical Systems
- Medtronic plc
- Micrel Medical Devices Sa
- Moog, Inc.
- Nestle Health Science
- Roche Diagnostics
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Tandem Diabetes Care Inc.
- Terumo Corp.
- Zyno Solutions LLC
For more information about this report visit https://www.researchandmarkets.com/r/j6wjop
